Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization.
- Author:
Ying-Lu FENG
1
;
Chang-Quan LING
;
Bai LI
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Aged; Carcinoma, Hepatocellular; drug therapy; Chemoembolization, Therapeutic; adverse effects; Dexamethasone; therapeutic use; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; therapeutic use; Female; Fever; chemically induced; Ginsenosides; therapeutic use; Humans; Liver Neoplasms; drug therapy; Male; Middle Aged; Phytotherapy; Syndrome; Vomiting; chemically induced
- From: Chinese Journal of Integrated Traditional and Western Medicine 2005;25(6):534-536
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effects of ginsenosides (GS) and low dose glucocorticoid for preventing and treating the post-transcatheter arterial chemoembolization (TACE) syndrome.
METHODSAdopting randomized, double blinded, controlled method, 80 patients with primary liver cancer were divided into 4 groups, placebo group, dexamethasone (Dex) group, Ginsenosides (GS) group, and Dex combined with GS group to observe the clinical effect of the patients after TACE.
RESULTSDex combined with GS could markedly lower the occurrence of nausea, vomiting, fever and pain, and the median time of symptoms persistence, also alleviate the bone marrow inhibition of chemotherapy.
CONCLUSIONDex combined with GS could effectively prevent and treat TACE syndrome.
